DexCom

Forecast & Rating29 analysts currently cover DexCom, with about 86.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $94.12, about 1.9% upside from the current price of $92.34. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 58.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study DexCom closely still see room for the stock to rise. Data as of Aug 13, 2026; for reference only and not investment advice.